Authors
Loading...
Genome editing improves fetal hemoglobin levels in sickle cell disease and β-thalassemia, highlighting enhancer role.
Lim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: